Immunotherapy for High Risk/Relapsed CD19+ Acute Lymphoblastic Leukaemia, B-cell Non-Hodgkin's Lymphoma (B-NHL) and Chronic Lymphocytic Leukaemia (CLL)/ Small Lymphocytic Lymphoma (SLL) Using CAR T-cells to Target CD19
Clinical trial NCT02935257 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02935257
- Sponsor
- University College, London
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-29
- Primary completion
- 2024-08-15
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.